InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (740 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
740
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Rothblatt Martine A, Founder, Chairperson, and Chief Executive Officer. Insider active across 2 companies, notably UNITED THERAPEUTICS Corp. In total, 1,023 filings have been recorded. Split: 0 buy · 740 sells. Total volume traded: €286.7m. History available since 10 September 2021. The latest transaction was disclosed on 23 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rothblatt Martine A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1,023 total
200 shares@ US$524.41750.0005% mcap0.0% of flowCommon StockSEC:0001106578-26-000131:11
9,500 shares@ US$135.420.0058% mcap0.2% of flowCommon StockSEC:0001106578-26-000131:0
480 shares@ US$514.2570.0011% mcap0.0% of flowCommon StockSEC:0001106578-26-000131:1
1,630 shares@ US$515.45870.0038% mcap0.1% of flowCommon StockSEC:0001106578-26-000131:2
2,386 shares@ US$516.15710.0055% mcap0.2% of flowCommon StockSEC:0001106578-26-000131:3
1,486 shares@ US$517.10730.0035% mcap0.1% of flowCommon StockSEC:0001106578-26-000131:4
1,346 shares@ US$518.14340.0031% mcap0.1% of flowCommon StockSEC:0001106578-26-000131:5
412 shares@ US$519.19250.0010% mcap0.0% of flowCommon StockSEC:0001106578-26-000131:6
751 shares@ US$520.29750.0018% mcap0.1% of flowCommon StockSEC:0001106578-26-000131:7
286 shares@ US$521.58150.0007% mcap0.0% of flowCommon StockSEC:0001106578-26-000131:8
517 shares@ US$522.40220.0012% mcap0.0% of flowCommon StockSEC:0001106578-26-000131:9
6 shares@ US$523.4250.0000% mcap0.0% of flowCommon StockSEC:0001106578-26-000131:10
9,500 shares@ US$135.420.0058% mcap0.2% of flowCommon StockSEC:0001106578-26-000130:0
704 shares@ US$513.40120.0016% mcap0.1% of flowCommon StockSEC:0001106578-26-000130:3
120 shares@ US$514.32010.0003% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:4
240 shares@ US$515.32990.0006% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:5
280 shares@ US$517.07030.0007% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:6
642 shares@ US$512.47140.0015% mcap0.1% of flowCommon StockSEC:0001106578-26-000130:2
120 shares@ US$531.120.0003% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:18
494 shares@ US$511.57510.0011% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:1
200 shares@ US$518.8940.0005% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:7
1,003 shares@ US$520.2340.0024% mcap0.1% of flowCommon StockSEC:0001106578-26-000130:8
477 shares@ US$521.23560.0011% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:9
280 shares@ US$522.40290.0007% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:10
240 shares@ US$523.600.0006% mcap0.0% of flowCommon StockSEC:0001106578-26-000130:11
25 of 1023 declarations
About Rothblatt Martine A
ROTHBLATT MARTINE A is Founder, Chairperson, and Chief Executive Officer, and also serves as Chairperson & CEO at UNITED THERAPEUTICS Corp and as Director at BETA Technologies, Inc. Across 598 filings in total, the 400 most recent filings cover the period from 2025-10-01 to 2026-07-09 and show only sales, for EUR 131333628; the listed filings are the 2026-05-01 filing at UNITED THERAPEUTICS Corp for EUR 1864504.520765315, the 2026-04-16 filing for EUR 1808146.280524264, the 2026-04-24 filing for EUR 1807397.69118175, the 2026-07-08 filing for EUR 1662326.708495125, the 2026-07-07 filing for EUR 1609987.382414076, and the 2026-04-27 filing for EUR 1558095.834488173.
